GCase-Targeting Parkinson Drug GT-02287 Shows Target Engagement, Encouraging Safety in Early-Stage Study

Scroll Top

Neurology Live

Aug 29 2024

May 14, 2025

https://www.bioworld.com/articles/720169-other-news-to-note-for-may-14-2025?v=preview

May 12, 2025

https://www.ddw-online.com/webinar-the-challenges-and-opportunities-in-neuroscience-drug-discovery-34758-202505/

March 19, 2025

https://parkinsonsnewstoday.com/news/first-parkinsons-patient-dosed-clinical-trial-gt-02287/